ViroPharma Announces That Treatment With HCV-796 Reduces Hepatitis C Virus Levels
10 nov. 2005 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced preliminary results from a Phase 1b proof of concept study with HCV-796, an orally dosed hepatitis C...
ViroPharma Announces Additional Investment for Vancocin Supply
03 nov. 2005 16h56 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 3, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the amendment of its manufacturing agreement with Eli Lilly and Company (Lilly) (NYSE:LLY) in order to...
ViroPharma to Release 2005 Third Quarter and Nine Month Financial Results On November 7, 2005
01 nov. 2005 09h00 HE
|
ViroPharma Incorporated
EXTON, Pa., Nov. 1, 2005 (PRIMEZONE) -- ViroPharma Incorporated's (Nasdaq:VPHM) third quarter and nine months 2005 financial results are expected to be released on Monday November 7, 2005, before the...
ViroPharma Announces Sponsorship of National Clostridium Difficile-Associated Disease Surveillance Project
10 oct. 2005 12h48 HE
|
ViroPharma Incorporated
EXTON, Pa., Oct. 10, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that the company has provided an unrestricted educational grant supporting the 'Clostridium...
Symposium On Clostridium difficile Highlights Difficulties in Containment and Increasing Severity of Disease
06 oct. 2005 16h31 HE
|
ViroPharma Incorporated
EXTON, Pa., Oct. 6, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced the presentation of data by industry thought leaders on the changing epidemiology of Clostridium...
ViroPharma Responds to Epidemic of Severe Disease Caused By Clostridium Difficile
26 sept. 2005 09h11 HE
|
ViroPharma Incorporated
EXTON, Pa., Sept. 26, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today reiterated that the company is engaged in efforts to meet the increased concerns of severe disease caused by an...
ViroPharma to Present at the 2005 UBS Global Life Sciences Conference
20 sept. 2005 11h01 HE
|
ViroPharma Incorporated
EXTON, Pa., Sept. 20, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it will present at 2005 UBS Global Life Sciences Conference, at 11:00 A.M. Eastern Time on Monday...
ViroPharma to Webcast 'Teach-In' On Clostridium Difficile Disease
12 sept. 2005 13h35 HE
|
ViroPharma Incorporated
EXTON, Pa., Sept. 12, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) announced today that the company will provide an audio webcast of its 'Teach-in' for investors on Clostridium...
ViroPharma Incorporated Reports Second Quarter and Six-Month 2005 Financial Results
02 août 2005 17h04 HE
|
ViroPharma Incorporated
EXTON, Pa., Aug. 2, 2005 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the second quarter and six-months ended June 30, 2005.
Net sales of...
ViroPharma to Release 2005 Second Quarter and Six Month Financial Results on August 2, 2005
26 juil. 2005 09h35 HE
|
ViroPharma Incorporated
EXTON, Pa., July 26, 2005 (PRIMEZONE) -- ViroPharma Incorporated's (Nasdaq:VPHM) second quarter and six months 2005 financial results are expected to be released on Tuesday, August 2, 2005 after the...